{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:48:34Z","timestamp":1762508914153,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Valvular heart disease remains common in both developed and developing countries, and it requires timely surgical treatment when necessary. However, the stability of hemodynamics during anesthesia induction in patients undergoing valve replacement surgery is difficult to maintain due to their impaired cardiac function. Remimazolam, a novel and ultrashort-acting intravenous sedative-hypnotic, may be beneficial to stable hemodynamics, but the evidence is limited. Therefore, this study aims to evaluate the effect of remimazolam induction on hemodynamics compared with midazolam and etomidate in patients undergoing valve replacement surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a prospective, multicenter randomized controlled trial (RCT). Three hundred and sixty-three non-obese adult patients aged 45 to 80\u00a0years old undergoing valve surgery with cardiopulmonary bypass will be randomly allocated to receive remimazolam tosilate, midazolam, or etomidate during anesthetic induction. The primary outcome is the incidence of hypotension within 20\u00a0min after the administration of investigated drugs. The hypotension is defined as systolic blood pressure (SBP)\u2009&lt;\u200990\u00a0mmHg or a 30% reduction in SBP from baseline or the application of vasoactive drugs. Secondary outcomes include incidence of successful sedation, time to successful sedation, incidence of delirium and postoperative low cardiac output syndrome within 7\u00a0days after surgery, hospital mortality, mechanical ventilation time, ICU length of stay, and hospital length of stay.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>To our knowledge, this is the first prospective RCT to investigate the efficacy and safety of remimazolam induction in adult cardiac surgery compared with midazolam and etomidate. This study will provide important information on the application of remimazolam in cardiac surgery in the future.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Chinese Clinical Trial Registry chictr.org.cn ChiCTR2100050122. Registered on August 16, 2021.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06965-8","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T11:10:25Z","timestamp":1670411425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of remimazolam for non-obese patients during anesthetic induction in cardiac surgery: study protocol for a multicenter randomized trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Hong","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-1694","authenticated-orcid":false,"given":"Peng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"issue":"11","key":"6965_CR1","doi-asserted-by":"publisher","first-page":"e052946","DOI":"10.1136\/bmjopen-2021-052946","volume":"11","author":"X Huang","year":"2021","unstructured":"Huang X, Dhruva SS, Yuan X, Bai X, Lu Y, Yan X, et al. Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study. BMJ Open. 2021;11(11):e052946. https:\/\/doi.org\/10.1136\/bmjopen-2021-052946.","journal-title":"BMJ Open"},{"issue":"3","key":"6965_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nrcardio.2010.202","volume":"8","author":"B Iung","year":"2011","unstructured":"Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8(3):162\u201372. https:\/\/doi.org\/10.1038\/nrcardio.2010.202.","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"6965_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41569-021-00570-z","volume":"18","author":"S Coffey","year":"2021","unstructured":"Coffey S, Roberts-Thomson R, Brown A, Carapetis J, Chen M, Enriquez-Sarano M, et al. Global epidemiology of valvular heart disease. Nat Rev Cardiol. 2021;18(12):853\u201364. https:\/\/doi.org\/10.1038\/s41569-021-00570-z.","journal-title":"Nat Rev Cardiol"},{"issue":"20","key":"6965_CR4","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1161\/CIR.0000000000000921","volume":"142","author":"RK Kumar","year":"2020","unstructured":"Kumar RK, Antunes MJ, Beaton A, Mirabel M, Nkomo VT, Okello E, et al. Contemporary diagnosis and management of rheumatic heart disease: implications for closing the gap: a scientific statement from the American Heart Association. Circulation. 2020;142(20):e337\u201357. https:\/\/doi.org\/10.1161\/CIR.0000000000000921.","journal-title":"Circulation"},{"issue":"12","key":"6965_CR5","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jacc.2018.06.063","volume":"72","author":"DA Watkins","year":"2018","unstructured":"Watkins DA, Beaton AZ, Carapetis JR, Karthikeyan G, Mayosi BM, Wyber R, et al. Rheumatic heart disease worldwide: JACC Scientific Expert Panel. J Am Coll Cardiol. 2018;72(12):1397\u2013416. https:\/\/doi.org\/10.1016\/j.jacc.2018.06.063.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"6965_CR6","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1053\/j.jvca.2021.06.015","volume":"35","author":"CGS Nabzdyk","year":"2021","unstructured":"Nabzdyk CGS, Read MD, Wieruszewski PM, Seelhammer TG. Proactive approach to peri-induction hemodynamic management in critically ill patients. J Cardiothorac Vasc Anesth. 2021;35(12):3489\u201392. https:\/\/doi.org\/10.1053\/j.jvca.2021.06.015.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"10","key":"6965_CR7","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s40265-021-01544-8","volume":"81","author":"A Lee","year":"2021","unstructured":"Lee A, Shirley M. Remimazolam: a review in procedural sedation. Drugs. 2021;81(10):1193\u2013201. https:\/\/doi.org\/10.1007\/s40265-021-01544-8.","journal-title":"Drugs"},{"issue":"5","key":"6965_CR8","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1213\/ANE.0b013e3182a705ae","volume":"117","author":"MT Worthington","year":"2013","unstructured":"Worthington MT, Antonik LJ, Goldwater DR, Lees JP, Wilhelm-Ogunbiyi K, Borkett KM, et al. A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy. Anesth Analg. 2013;117(5):1093\u2013100. https:\/\/doi.org\/10.1213\/ANE.0b013e3182a705ae.","journal-title":"Anesth Analg"},{"issue":"9","key":"6965_CR9","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/phar.1806","volume":"36","author":"AM Wesolowski","year":"2016","unstructured":"Wesolowski AM, Zaccagnino MP, Malapero RJ, Kaye AD, Urman RD. Remimazolam: pharmacologic considerations and clinical role in anesthesiology. Pharmacotherapy. 2016;36(9):1021\u20137. https:\/\/doi.org\/10.1002\/phar.1806.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"6965_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s40265-020-01299-8","volume":"80","author":"SJ Keam","year":"2020","unstructured":"Keam SJ. Remimazolam: first approval. Drugs. 2020;80(6):625\u201333. https:\/\/doi.org\/10.1007\/s40265-020-01299-8.","journal-title":"Drugs"},{"key":"6965_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2147\/DDDT.S186759","volume":"13","author":"N Freyer","year":"2019","unstructured":"Freyer N, Knospel F, Damm G, Greuel S, Schneider C, Seehofer D, et al. Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system. Drug Des Devel Ther. 2019;13:1033\u201347. https:\/\/doi.org\/10.2147\/DDDT.S186759.","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"6965_CR12","doi-asserted-by":"publisher","first-page":"e00851","DOI":"10.1002\/prp2.851","volume":"9","author":"T Liu","year":"2021","unstructured":"Liu T, Lai T, Chen J, Lu Y, He F, Chen Y, et al. Effect of remimazolam induction on hemodynamics in patients undergoing valve replacement surgery: a randomized, double-blind, controlled trial. Pharmacol Res Perspect. 2021;9(5):e00851. https:\/\/doi.org\/10.1002\/prp2.851.","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"6965_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40981-021-00424-0","volume":"7","author":"K Saito","year":"2021","unstructured":"Saito K, Ohno S, Maeda M, Hirata N, Yamakage M. Remimazolam anesthesia for cardiac surgery with cardiopulmonary bypass: a case report. JA Clin Rep. 2021;7(1):21. https:\/\/doi.org\/10.1186\/s40981-021-00424-0.","journal-title":"JA Clin Rep"},{"key":"6965_CR14","doi-asserted-by":"publisher","first-page":"5536442","DOI":"10.1155\/2021\/5536442","volume":"2021","author":"T Satoh","year":"2021","unstructured":"Satoh T, Nishihara N, Sawashita Y, Ohno S, Hirata N, Yamakage M. Remimazolam anesthesia for MitraClip implantation in a patient with advanced heart failure. Case Rep Anesthesiol. 2021;2021:5536442. https:\/\/doi.org\/10.1155\/2021\/5536442.","journal-title":"Case Rep Anesthesiol"},{"issue":"34","key":"6965_CR15","doi-asserted-by":"publisher","first-page":"10595","DOI":"10.12998\/wjcc.v9.i34.10595","volume":"9","author":"F Tang","year":"2021","unstructured":"Tang F, Yi JM, Gong HY, Lu ZY, Chen J, Fang B, et al. Remimazolam benzenesulfonate anesthesia effectiveness in cardiac surgery patients under general anesthesia. World J Clin Cases. 2021;9(34):10595\u2013603. https:\/\/doi.org\/10.12998\/wjcc.v9.i34.10595.","journal-title":"World J Clin Cases"},{"issue":"3","key":"6965_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00380-017-1049-5","volume":"33","author":"M Zuin","year":"2018","unstructured":"Zuin M, Rigatelli G, Dell\u2019Avvocata F, Faggian G, Conte L, Giatti S, et al. Ketamine and midazolam differently impact post-intubation hemodynamic profile when used as induction agents during emergency airway management in hemodynamically stable patients with ST elevation myocardial infarction. Heart Vessels. 2018;33(3):213\u201325. https:\/\/doi.org\/10.1007\/s00380-017-1049-5.","journal-title":"Heart Vessels"},{"issue":"3","key":"6965_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","volume":"88","author":"DK Rex","year":"2018","unstructured":"Rex DK, Bhandari R, Desta T, DeMicco MP, Schaeffer C, Etzkorn K, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018;88(3):427-37.e6. https:\/\/doi.org\/10.1016\/j.gie.2018.04.2351.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"6965_CR18","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1053\/j.jvca.2020.11.068","volume":"35","author":"YT Yao","year":"2021","unstructured":"Yao YT, He LX, Fang NX, Ma J. Anesthetic induction with etomidate in cardiac surgical patients: a PRISMA-compliant systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2021;35(4):1073\u201385. https:\/\/doi.org\/10.1053\/j.jvca.2020.11.068.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"3","key":"6965_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/ALN.0000000000000087","volume":"120","author":"CE Wagner","year":"2014","unstructured":"Wagner CE, Bick JS, Johnson D, Ahmad R, Han X, Ehrenfeld JM, et al. Etomidate use and postoperative outcomes among cardiac surgery patients. Anesthesiology. 2014;120(3):579\u201389. https:\/\/doi.org\/10.1097\/ALN.0000000000000087.","journal-title":"Anesthesiology"},{"issue":"10","key":"6965_CR20","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s40262-021-01038-6","volume":"60","author":"BI Valk","year":"2021","unstructured":"Valk BI, Struys M. Etomidate and its analogs: a review of pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2021;60(10):1253\u201369. https:\/\/doi.org\/10.1007\/s40262-021-01038-6.","journal-title":"Clin Pharmacokinet"},{"key":"6965_CR21","doi-asserted-by":"publisher","first-page":"Cd003843","DOI":"10.1002\/14651858.CD003843.pub2","volume":"4","author":"Y Punjasawadwong","year":"2007","unstructured":"Punjasawadwong Y, Boonjeungmonkol N, Phongchiewboon A. Bispectral index for improving anaesthetic delivery and postoperative recovery. Cochrane Database Syst Rev. 2007;4:Cd003843. https:\/\/doi.org\/10.1002\/14651858.CD003843.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"6965_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bja.2018.09.027","volume":"122","author":"JA Hannam","year":"2019","unstructured":"Hannam JA, Mitchell SJ, Cumin D, Frampton C, Merry AF, Moore MR, et al. Haemodynamic profiles of etomidate vs propofol for induction of anaesthesia: a randomised controlled trial in patients undergoing cardiac surgery. Br J Anaesth. 2019;122(2):198\u2013205. https:\/\/doi.org\/10.1016\/j.bja.2018.09.027.","journal-title":"Br J Anaesth"},{"issue":"21","key":"6965_CR23","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1001\/jama.286.21.2703","volume":"286","author":"EW Ely","year":"2001","unstructured":"Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286(21):2703\u201310. https:\/\/doi.org\/10.1001\/jama.286.21.2703.","journal-title":"JAMA"},{"issue":"1","key":"6965_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40981-022-00528-1","volume":"8","author":"A Kitaura","year":"2022","unstructured":"Kitaura A, Kosumi R, Iwamoto T, Nakao S. Remimazolam anesthesia for transcatheter mitral valve repair in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome: a case report. JA Clin Rep. 2022;8(1):38. https:\/\/doi.org\/10.1186\/s40981-022-00528-1.","journal-title":"JA Clin Rep"},{"issue":"1","key":"6965_CR25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12871-021-01422-6","volume":"21","author":"M Furuta","year":"2021","unstructured":"Furuta M, Ito H, Yamazaki M. Anaesthetic management using remimazolam in a patient with severe aortic stenosis: a case report. BMC Anesthesiol. 2021;21(1):202. https:\/\/doi.org\/10.1186\/s12871-021-01422-6.","journal-title":"BMC Anesthesiol"},{"issue":"4","key":"6965_CR26","doi-asserted-by":"publisher","first-page":"368504211052354","DOI":"10.1177\/00368504211052354","volume":"104","author":"L Chen","year":"2021","unstructured":"Chen L, Lu K, Luo T, Liang H, Gui Y, Jin S. Observer\u2019s Assessment of Alertness\/Sedation-based titration reduces propofol consumption and incidence of hypotension during general anesthesia induction: a randomized controlled trial. Sci Prog. 2021;104(4):368504211052354. https:\/\/doi.org\/10.1177\/00368504211052354.","journal-title":"Sci Prog"},{"issue":"2","key":"6965_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4103\/aer.aer_81_21","volume":"15","author":"RK Thirunelli","year":"2021","unstructured":"Thirunelli RK, Nanjundaswamy NH. A Prospective observational study of plethysmograph variability index and perfusion index in predicting hypotension with propofol induction in noncardiac surgeries. Anesth Essays Res. 2021;15(2):167\u201373. https:\/\/doi.org\/10.4103\/aer.aer_81_21.","journal-title":"Anesth Essays Res"},{"key":"6965_CR28","doi-asserted-by":"publisher","first-page":"CD009491","DOI":"10.1002\/14651858.CD009491.pub2","volume":"5","author":"A Conway","year":"2016","unstructured":"Conway A, Rolley J, Sutherland JR. Midazolam for sedation before procedures. Cochrane Database Syst Rev. 2016;5:CD009491. https:\/\/doi.org\/10.1002\/14651858.CD009491.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"6965_CR29","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1007\/s11695-019-03952-y","volume":"29","author":"S Pouwels","year":"2019","unstructured":"Pouwels S, Buise MP, Twardowski P, Stepaniak PS, Proczko M. Obesity surgery and anesthesiology risks: a review of key concepts and related physiology. Obes Surg. 2019;29(8):2670\u20137. https:\/\/doi.org\/10.1007\/s11695-019-03952-y.","journal-title":"Obes Surg"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06965-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06965-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06965-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T11:11:27Z","timestamp":1670411487000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06965-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6965"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06965-8","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2022,12,7]]},"assertion":[{"value":"28 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol has been approved by the Ethics Committee of West China Hospital of Sichuan University [Ethics Committee No. 2021(225)] and registered at chictr.org.cn (ID: ChiCTR2100050122) on August 16, 2021. All patients will provide written informed consent before the start of any protocol-specified procedures or assessments. The patients can withdraw from the trial at any time. The results of the study will be presented at relevant conferences and submitted to international peer-reviewed journals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable\u2014no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. Informed consent materials are available from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"984"}}